Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Publication of Preclinical Data Showing Ability of the Hemopurifier to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys
C2000-2021 InvestorIdeas.com tm
Read more: https://www.investorideas.com/news/2024/08271AEMD-Hemopurifier-Preclinical-data.asp
Text source: Investorideas.com newswire, breaking stock market